Marcie A. Goldstein
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/13064_goldstei_0.jpg?itok=i1lZSem0)
Filters
Personalis $125 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $125 million public offering of common stock by Personalis, Inc. The common stock…
IDEAYA Biosciences $50 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by IDEAYA Biosciences, Inc. of its common stock for up to an aggregate amount of $50 million.
Based in…
KE Holdings $2.12 billion IPO and NYSE listing
Davis Polk advised the representatives of the underwriters on KE Holdings’ initial public offering of 106,000,000 American depositary shares, for total proceeds of $2.12 billion. KE…
Atreca $100 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Atreca, Inc. of its common stock for up to an aggregate amount of $100 million.
Atreca is a…
Oak Street Health $377.3 million IPO
Davis Polk advised the joint book running managers in connection with the $377.3 million initial public offering of 17,968,750 shares of common stock of Oak Street Health, Inc., which…
Rocket Companies $1.8 billion IPO and NYSE listing
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket Companies, Inc. of 100,000,000 shares of Rocket Companies’ Class…
Turning Point Therapeutics $250 million at-the-market offering
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its common stock for up to an aggregate amount of $250 million…
Rackspace Technology $703.5 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $703.5 million initial public offering of 33,500,000 shares of common stock of Rackspace Technology…
CC Neuberger Principal Holdings II $828 million IPO
Davis Polk advised the representative of the several underwriters in connection with the initial public offering of 82,800,00 units of CC Neuberger Principal Holdings II, including 10,800…
BioXcel Therapeutics $200 million stock offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 4,000,000 shares of its common stock. The common stock is listed on the…